PBAC's latest decision on Pbs listed otc drugs: Noted (2015). Considered for This is a policy decision document regarding removal of over-the-counter medicines from the PBS, not a submission for a specific drug.
PBAC outcome
Noted
Not applicable
ICER (AUD/QALY)
Not modelled
no economic evaluation
Submissions
1
first 2015
Submissions
1
2015 → 2015
Eligible population
Multiple OTC products listed on the PBS; the PBAC identified categories for retention (emergency medicines, NRT, palliative care, nutritional products for metabolic disorders, ATSI products, IV delivery products) and proposed delisting of low-cost OTC products with ex-manufacturer price below the concessional co-payment.
Therapy area
Other
Line of therapy
Not applicable
Evidence base
Other
Economic model
BIA only
ICER note
No ICER calculated; this is a policy/delisting review, not a drug submission.